The Drug Enforcement Administration is amending the table of Excluded Nonnarcotic Products to update the company name for the drug product Nasal Decongestant Inhaler/Vapor Inhaler (containing 50 milligrams levmetamfetamine) to Aphena Pharma Solutions--New York, LLC. This over-the-counter, nonnarcotic drug product is excluded from the provisions of the Controlled Substances Act.
Document
Schedules of Controlled Substances: Table of Excluded Nonnarcotic Products: Nasal Decongestant Inhaler/Vapor Inhaler
The Drug Enforcement Administration is amending the table of Excluded Nonnarcotic Products to update the company name for the drug product Nasal Decongestant Inhaler/Vapor Inhal...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
80 FR 65632
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Schedules of Controlled Substances: Table of Excluded Nonnarcotic Products: Nasal Decongestant Inhaler/Vapor Inhaler,” thefederalregister.org (October 27, 2015), https://thefederalregister.org/documents/2015-27264/schedules-of-controlled-substances-table-of-excluded-nonnarcotic-products-nasal-decongestant-inhaler-vapor-inhaler.